Trial Profile
Reduction of Ischemic Myocardium With Ranolazine-Treatment in Patients With Acute Myocardial Ischemia
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Ranolazine (Primary)
- Indications Myocardial ischaemia
- Focus Proof of concept; Therapeutic Use
- Acronyms RIMINI-Pilot
- 10 Jun 2015 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.
- 23 May 2013 New source identified and integrated (European Clinical Trials Database, EudraCT2013-000030-35).
- 08 May 2013 Status changed from not yet recruiting to recruiting as reported by European Clinical Trials Database.